Healthcare - Press Releases

  • 1085 Press Releases ยท
  • RSS
Published on Mon 24 Mar 2025 9:26:21 UTC
MILAN, 24 mars 2025 /PRNewswire/ -- Newronika, leader de la neuromodulation et de la technologie de stimulation crbrale profonde (SCP) adaptative, a annonc aujourd'hui avoir reu l'approbation du marquage CE pour son dispositif AlphaDBS, un systme de SCP de nouvelle gnration fonctionnant en boucle ferme, et qui ajuste dynamiquement la stimulation en fonction des signaux crbraux en temps rel. Cette approbation permet l'entreprise de commercialiser AlphaDBS en Europe, offrant ainsi une option thrapeutique innovante aux patients atteints de la maladie de Parkinson et d'autres troubles neurologiques.
Published on Mon 24 Mar 2025 9:26:19 UTC
MAILAND, 24. Mrz 2025 /PRNewswire/ -- Newronika, ein fhrendes Unternehmen im Bereich der Neuromodulation und adaptiven Tiefenhirnstimulation (THS), gab heute bekannt, dass es die CE-Kennzeichnung fr sein AlphaDBS-Gert erhalten hat, ein THS-System der nchsten Generation mit geschlossenem Regelkreis, das die Stimulation dynamisch auf der Grundlage von Echtzeit-Gehirnsignalen anpasst. Diese Zulassung ermglicht es dem Unternehmen, AlphaDBS in Europa zu vermarkten und Patienten mit Parkinson und anderen neurologischen Erkrankungen eine innovative Behandlungsmglichkeit zu bieten.
Published on Mon 24 Mar 2025 9:26:14 UTC
Rise in prevalence of cardiovascular diseases (CVDS), expanding applications in pain management & fever reduction, and government & healthcare initiatives promoting preventive medicine drive the growth of the global aspirin drugs market.
Published on Mon 24 Mar 2025 9:22:45 UTC
NORTH CHICAGO, Ill., March 24, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, demonstrates how to elevate the patient experience and achieve optimal treatment outcomes with new AA Signature program at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from Thursday, March 27- Saturday, March 29, 2025.
Published on Fri 21 Mar 2025 12:11:03 UTC
SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ --Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milestones achieved in recent months.
Published on Fri 21 Mar 2025 12:10:40 UTC
The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb-ATR marketing applications in 2025
Published on Fri 21 Mar 2025 12:10:01 UTC
BEIJING, March 21, 2025 /PRNewswire/ --Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leaderAstraZenecato develop potential first-in-class macrocyclic peptides for the treatment of chronic diseases.Under this collaboration,AstraZeneca will gain access toSyneron Bio's innovative Synova platform, an intelligentand high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases,including rare, autoimmune,and metabolic disease.
Published on Fri 21 Mar 2025 12:10:00 UTC
Announced merger agreement with Cullgen in November, anticipated to close in the first half of 2025
Published on Fri 21 Mar 2025 12:09:47 UTC
- Convocatoria final: EIT Jumpstarter 2025 da la bienvenida a innovadores de toda Europa, con especial atencin a los Balcanes, el Mediterrneo y las regiones ultraperifricas de la UE
Published on Fri 21 Mar 2025 12:09:46 UTC
HAYWARD, Calif., March 21, 2025 /PRNewswire/ -- Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn's Chief Transformation Officer, will transition to a new role leading the company as Chief Executive Officer. Dunn succeeds Sanjay Banerjee, who is stepping down from his role as CEO.
Published on Fri 21 Mar 2025 12:01:27 UTC
MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.
Published on Fri 21 Mar 2025 12:01:24 UTC
MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.
Published on Fri 21 Mar 2025 12:01:21 UTC
GILBERT, Ariz., 21 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Recibir atencin mdica de calidad ahora es ms fcil en Gilbert! MY DR NOW est abriendo una nueva clnica de atencin primaria diseada para adaptarse a su horario abierto los siete das de la semana con horario extendido .
Published on Fri 21 Mar 2025 12:01:13 UTC
- Winners received prestigious award in recognition of their latest innovations in life sciences advancement
Published on Fri 21 Mar 2025 12:01:11 UTC
GILBERT, Ariz., March 21, 2025 /PRNewswire/ -- Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule-open seven days a week with extended hours.
Published on Fri 21 Mar 2025 12:01:08 UTC
GILBERT, Ariz., March 21, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule-open seven days a week with extended hours.
Published on Fri 21 Mar 2025 12:01:06 UTC
ATLANTA, March 21, 2025 /PRNewswire/ --Applications are now being accepted forApolloMD's 2025Emergency Medicine Scholarship for Residents.
Published on Fri 21 Mar 2025 12:00:55 UTC
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Published on Fri 21 Mar 2025 12:00:52 UTC
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- HarbourBioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, today announced a global strategic collaboration with AstraZeneca to discoverand developnext-generation multi-specific antibodies for immunology, oncology and beyond. The strategic collaboration includes an option to license multiple programs utilizing Harbour BioMed's proprietary Harbour Mice fully human antibody technology platform in multiple therapeutic areas and a$105 million equity investment by AstraZeneca in Harbour BioMed.
Published on Fri 21 Mar 2025 12:00:49 UTC
PRINCETON, N.J., March 21, 2025 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,announced today its recent accomplishments and financial results for the year ended December 31, 2024.
Published on Fri 21 Mar 2025 12:00:44 UTC
Gundry MD Total Restore is a unique dietary supplement that contains L-Glutamine as one of its key ingredients. It is specifically designed to address common gut health issues such as occasional gas, bloating, digestive problems, cravings for unhealthy foods, and unwanted weight gain, and aims to support overall health and well-being.
Published on Fri 21 Mar 2025 11:48:29 UTC
AMSTERDAM, March 21, 2025 /PRNewswire/ -- From March 11 to 14,Aquatech Amsterdam 2025, a premier global event in water treatment, took place at the RAI Amsterdam Convention Centre. Recognized as an industry-leading exhibition covering all aspects of water treatment, this year's event drew over 900 exhibitors, 25,000 professional visitors, and extensive international media coverage.
Published on Fri 21 Mar 2025 11:45:57 UTC
Final chance to join Europe's top pre-accelerator for EU entrepreneurs, featuring special prizes for innovators from key emerging regions
Published on Fri 21 Mar 2025 11:45:54 UTC
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new semaglutide cardiovascular data and the surprising parallels between parakeet and human brain activity.
Published on Fri 21 Mar 2025 7:21:10 UTC
HOUSTON, March 20, 2025 /PRNewswire/ -- PCCA, a leading FDA-registered supplier of active pharmaceutical ingredients, excipients and consulting for the compounding industry, today announced Gus Bassani, PharmD,will become chief executive officer of its U.S. business unit on April 1, elevating a company veteran with extensive scientific leadership.